Concepedia

Joseph P. Gardner

JP

8

Publications

2.6K

Citations

8

H-Index

1994

Active since

Affiliations

Pfizer (United States)(Current)

University of California, San Francisco

Joseph P. Gardner is an author at Pfizer (United States) specializing in antibody engineering, medicine, and pharmacology.

Top concepts

Publications per year

1994–2017

8

Publications

8

Discovery of a Novel, Potent, and Src Family-selective Tyrosine Kinase Inhibitor

Jeffrey H. Hanke, Joseph P. Gardner, Robert L. Dow et al. · Journal of Biological Chemistry · 1996 · 1.9K citations · Full text

The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A

Ellen Chuang, Timothy S. Fisher, Rodney Morgan et al. · Immunity · 2000 · 292 citations · Full text

Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay

J. Perry Hall, Amy Brault, Fabien Vincent et al. · PLoS ONE · 2017 · 157 citations · Full text

Vaccination with Cancer- and HIV Infection-Associated Endogenous Retrotransposable Elements Is Safe and Immunogenic

Jonah B. Sacha, In-Jeong Kim, Lianchun Chen et al. · The Journal of Immunology · 2012 · 54 citations · Full text

Potent Activation of Phosphatidylinositol 3'-Kinase by Simple Phosphotyrosine Peptides Derived from Insulin Receptor Substrate 1 Containing Two YMXM Motifs for binding SH2 Domains

John J. Herbst, Glenn C. Andrews, Leonard G. Contillo et al. · Biochemistry · 1994 · 48 citations

Rows per page

1–5 of 8